These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26978596)

  • 21. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.
    Luo L; Lin T; Zheng S; Xie Z; Chen M; Lian G; Xu C; Wang H; Xie L
    Clin Exp Hypertens; 2015; 37(3):241-8. PubMed ID: 25271670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
    Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats.
    Li XQ; Wang HM; Yang CG; Zhang XH; Han DD; Wang HL
    Acta Pharmacol Sin; 2011 Feb; 32(2):217-22. PubMed ID: 21217769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension.
    Zhang LL; Lu J; Li MT; Wang Q; Zeng XF
    Int J Rheum Dis; 2016 Feb; 19(2):192-8. PubMed ID: 24612527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystamine slows but not inverses the progression of monocrotaline-induced pulmonary arterial hypertension in rats.
    Wang HM; Liu WZ; Tang FT; Sui HJ; Zhan XJ; Wang HX
    Can J Physiol Pharmacol; 2018 Aug; 96(8):783-789. PubMed ID: 29633623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.
    Zhang D; Wang G; Han D; Zhang Y; Xu J; Lu J; Li S; Xie X; Liu L; Dong L; Li M
    Life Sci; 2014 Mar; 98(1):39-43. PubMed ID: 24412385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats.
    Tang B; Chen GX; Liang MY; Yao JP; Wu ZK
    Int J Cardiol; 2015 Feb; 180():134-41. PubMed ID: 25438234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eukaryotic elongation factor 2 kinase mediates monocrotaline-induced pulmonary arterial hypertension via reactive oxygen species-dependent vascular remodeling.
    Kameshima S; Kazama K; Okada M; Yamawaki H
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1298-305. PubMed ID: 25770246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Jiang L; Zhou T; Liu H
    Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of endocan attenuates monocrotaline-induced connective tissue disease related pulmonary arterial hypertension.
    Zhao H; Xue Y; Guo Y; Sun Y; Liu D; Wang X
    Int Immunopharmacol; 2017 Jan; 42():115-121. PubMed ID: 27912147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway.
    Ouyang S; Chen W; Gaofeng Z; Changcheng L; Guoping T; Minyan Z; Yang L; Min Y; Luo J
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
    Alencar AK; Pereira SL; da Silva FE; Mendes LV; Cunha Vdo M; Lima LM; Montagnoli TL; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; Sant'anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Int J Cardiol; 2014 May; 173(2):154-62. PubMed ID: 24630383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70.
    Chen F; Wang H; Yan J; Lai J; Cai S; Yuan L; Zheng S
    Biomed Pharmacother; 2018 May; 101():123-128. PubMed ID: 29482057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.